《外科腫瘤學(xué)年鑒》專門為所有專業(yè)的執(zhí)業(yè)外科醫(yī)生帶來最新、最重要的發(fā)展，包括多學(xué)科的癌癥護(hù)理和研究。每期都有關(guān)于多學(xué)科癌癥護(hù)理、癌癥患者外科護(hù)理以及臨床相關(guān)癌癥研究結(jié)果的原創(chuàng)文章；與癌癥外科患者多學(xué)科管理相關(guān)的小型課程和研討會(huì)；以及關(guān)于基礎(chǔ)科學(xué)進(jìn)步、手術(shù)進(jìn)展、輔助治療、癌癥預(yù)防、康復(fù)以及涉及癌癥患者的社會(huì)經(jīng)濟(jì)問題的教育評(píng)論。《外科腫瘤學(xué)年鑒》（ASO）通過交流研究和教育的進(jìn)展，促進(jìn)高質(zhì)量的外科腫瘤學(xué)管理，這些研究和教育對(duì)于為癌癥患者提供當(dāng)代多學(xué)科護(hù)理具有重要意義。外科腫瘤學(xué)學(xué)會(huì)（SSO）和美國乳腺外科醫(yī)師學(xué)會(huì)（ASO）的官方雜志，是全球外科腫瘤學(xué)研究和教育方面的選擇雜志。《外科腫瘤學(xué)年鑒》的使命是：1）在全國和世界范圍內(nèi)代表和推進(jìn)外科腫瘤學(xué)專業(yè)；2）促進(jìn)最高質(zhì)量的多學(xué)科患者護(hù)理和實(shí)踐管理；3）使用印刷和電子媒體提供相關(guān)的癌癥教育和研究培訓(xùn)材料；4）促進(jìn)臨床和轉(zhuǎn)化癌癥研究，重點(diǎn)是臨床試驗(yàn)；5）促進(jìn)外科受訓(xùn)人員的職業(yè)發(fā)展及其向?qū)W術(shù)和社區(qū)實(shí)踐的過渡；6）促進(jìn)與癌癥外科患者有關(guān)的公共政策和患者宣傳問題。

Annals of Surgical Oncology is specifically designed to bring the latest, most significant developments involving multidisciplinary cancer care and research to the practicing surgeon from all specialties. Each issue features original articles on multidisciplinary cancer care, surgical care of the cancer patient, and results of clinically-relevant cancer research; mini-courses and symposia related to multidisciplinary management of surgical patients with cancer; and educational reviews about basic science advances, advances in surgery, adjuvant therapies, cancer prevention, rehabilitation, and socioeconomic issues involving the cancer patient.The Annals of Surgical Oncology (ASO) promotes high-quality surgical oncology management by communicating advances in research and education that are relevant and valuable to the provision of contemporary multidisciplinary care for patients with cancer.The official journal of the Society of Surgical Oncology (SSO) and the American Society of Breast Surgeons, ASO is the journal of choice of surgical oncologists worldwide regarding surgical oncology research and education.The mission of the Annals of Surgical Oncology is to serve its readers by 1) representing and advancing the profession of surgical oncology throughout the nation and the world; 2) promoting the highest quality multidisciplinary patient care and practice management; 3) providing relevant cancer education and research training materials using print and electronic media; 4) promoting clinical and translational cancer research, with an emphasis on clinical trials; 5) facilitating the career development of surgical trainees and their transition into academic and community-based practice; and 6) promoting public policy and patient advocacy issues related to surgical patient with cancer.